We investigated the functional consequences of celecoxib on programmed cell death type I (apoptosis) and type II (autophagy), whether celecoxib inhibited glioma proliferation by p53-dependent induction of apoptosis or autophagy. The gene discussed is TP53; the disease is glioma.